Clinical trial
Pulmonary Vein Isolation With Versus Without Continued Antiarrhythmic Drug Treatment in Subjects With Recurrent Atrial Fibrillation: A Prospective 2-Centre Randomized Controlled Clinical Study (POWDER-AF)
NCT02475642 is registered in ClinicalTrials.gov with VZW Cardiovascular Research Center Aalst as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pulmonary Vein Isolation With Versus Without Continued Antiarrhythmic Drug Treatment in Subjects With Recurrent Atrial Fibrillation: A Prospective 2-Centre Randomized Controlled Clinical Study (POWDER-AF)
- Lead sponsor
- VZW Cardiovascular Research Center Aalst
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- March 31, 2014
- Completion date
- August 31, 2016
- Enrollment
- 152 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.